Presentation TCT 2016 TCT 137: Influence of Nonculprit Lesions Management on Outcomes in Patients Over 75 Years Old With ST Elevated Myocardial Infarction. Results From the ESTROFA MI+75 Nationwide Registry Presenter: Warren J. Cantor, Thomas D. Stuckey October 30, 2016
Presentation TCT 2016 Medical Therapy, Revascularization, and CRT for Functional Mitral Regurgitation: Despite Class I Guidelines, Are the Benefits Substantial? Presenter: Ted Feldman, Allan Schwartz, JoAnn Lindenfeld October 30, 2016
News Conference News TCT 2016 LEADERS FREE: Polymer-Free DES Maintains Superior Safety, Efficacy Over BMS at 2 Years Yael L. Maxwell October 30, 2016
News Conference News TCT 2016 ‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent Michael O'Riordan October 30, 2016
News Conference News TCT 2016 ILUMIEN III: OCT Imaging Matches IVUS but Fails to Beat Angiography for Stent Guidance in PCI Shelley Wood October 30, 2016
News Opinion Editor's Corner TCT 2016 TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever Shelley Wood October 24, 2016
News Conference News TCT 2015 Nordic-Baltic Bifurcation III: Kissing Balloon Dilatation Does Not Reduce MACE at 5 Years October 16, 2015
Presentation TCT 2015 Optimal Pharmacology in the Diabetic: What's Here? What's New? What's in the Pipeline? Presenter: Frederick Feit, David J. Maron, Norman E. Lepor October 15, 2015
Presentation TCT 2015 Do Contemporary DES Change the Equation for PCI vs CABG in the Diabetic Patient? Presenter: Frederick Feit, David J. Maron, Sripal Bangalore October 15, 2015
Presentation TCT 2015 Pros and Cons of CABG vs PCI in the Diabetic Patient With Multivessel Disease: Insights From Randomized Trials Presenter: Frederick Feit, David J. Maron, Michael E. Farkouh October 15, 2015
Presentation TCT 2015 Sorting Through Revascularization Choices in Left Main and Multivessel Disease: A Practical Approach Presenter: Jeffrey W. Moses, Erick Schampaert October 14, 2015
Presentation TCT 2015 The Role (and Timing) of Complete Revascularization in AMI and Cardiogenic Shock Presenter: Tanveer Rab, Holger Thiele October 14, 2015
Presentation TCT 2015 Debate: Is Transcarotid Artery Revascularization a Revolutionary Advance? No, It Is Too Complex and There Is No Advantage for the Patient! Presenter: William A. Gray, D. Christopher Metzger, Bernhard Reimers October 14, 2015
Presentation TCT 2015 Debate: Is Transcarotid Artery Revascularization a Revolutionary Advance? Yes, It Is a Game Changer for Both Outcomes and Adoption of Carotid Stenting! Presenter: William A. Gray, D. Christopher Metzger, Christopher J. Kwolek October 14, 2015
Presentation TCT 2015 Evidence Review: Revascularization in LV Dysfunction After STICH Who Might Benefit? Presenter: Robert O. Bonow, Ajay J. Kirtane October 14, 2015
Presentation TCT 2015 CTO Revascularization: 2015 Update Presenter: Larry S. Dean, Simon R. Dixon, Mauro Carlino October 14, 2015
Presentation TCT 2015 For This Patient, I Suggest Hybrid Coronary Revascularization (Lets Split the Difference) Presenter: John D. Puskas October 14, 2015
Presentation TCT 2015 Stable CAD With Substantial Ischemia and No-to-Mild Symptoms: Initial Revascularization vs Medical Therapy Presenter: William A. Gray, Gregg W. Stone, D. Christopher Metzger, Sripal Bangalore October 14, 2015
News Conference News TCT 2015 TWENTE: ZES, EES Convey Similar Safety, Efficacy Results at 5 Years October 14, 2015
News Conference News TCT 2015 TUXEDO-India Affirms Superiority of EES in Patients With Diabetes Todd Neale October 14, 2015